Sofinnova Investments’s Exact Sciences EXAS Stock Holding History

Sofinnova Investments’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-101,443	Closed	-$10.3M	–	80
2025 Q4	$10.3M	Sell	101,443 -263,557	-72%	-$21.2M	0.44%	42
2025 Q3	$20M	Buy	365,000 +156,700	+75%	+$7.83M	1.09%	28
2025 Q2	$11.1M	Buy	+208,300	New	+$10.6M	0.68%	39
2025 Q1	–	Sell	-52,042	Closed	-$2.92M	–	74
2024 Q4	$2.92M	Buy	52,042 +14,405	+38%	+$896K	0.21%	45
2024 Q3	$2.56M	Sell	37,637 -144,191	-79%	-$8.14M	0.2%	49
2024 Q2	$7.68M	Sell	181,828 -47,653	-21%	-$2.62M	0.4%	48
2024 Q1	$15.8M	Buy	+229,481	New	+$14.5M	0.88%	30

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Sofinnova Investments's EXAS Position: Q1 2026 in Review

Sofinnova Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 101,443 shares — an estimated $10.3M sold.

Sofinnova Investments first reported a position in EXAS in Q1 2024 and held it in 7 quarters. The position peaked at $20M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Sofinnova Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Sofinnova Investments sold 101,443 Exact Sciences shares in Q1 2026, an estimated $10.3M.
Sofinnova Investments first reported a position in Exact Sciences in Q1 2024 and held it in 7 quarters.
Sofinnova Investments's Exact Sciences position peaked at $20M in Q3 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.